Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
JIB-04 Inhibits Colorectal Cancer Stem Cells via Wnt/β-Caten
2026-05-05
This study demonstrates that JIB-04, a pan-selective histone demethylase inhibitor, selectively targets colorectal cancer stem cells (CSCs) by suppressing the Wnt/β-catenin signaling pathway. The findings highlight an effective epigenetic strategy to reduce CSC-driven tumor recurrence and suggest complementary avenues for histone methyltransferase inhibitor research.
-
Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R
2026-05-04
This study establishes a scalable protocol to differentiate human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons capable of supporting latent HSV-1 infection and reactivation. The model enables direct investigation of neuron-intrinsic mechanisms underlying HSV-1 latency, offering a pivotal advance over animal-based systems.
-
Tariquidar (XR9576) in Drug Resistance Research: Practical W
2026-05-04
Tariquidar (XR9576) offers unmatched precision for dissecting P-glycoprotein-driven drug resistance, even in challenging high-viscosity tumor models. This guide delivers actionable protocols and troubleshooting strategies, bridging cutting-edge mechanobiology insights with hands-on cancer chemoresistance studies.
-
Innovations in HA Tag Peptide Assays: Mechanistic Insights a
2026-05-03
Explore the Influenza Hemagglutinin (HA) Peptide as a HA tag peptide for cutting-edge protein tagging and immunoprecipitation workflows. This article delivers a mechanistic, assay-focused perspective, integrating new chemoproteomic insights and practical protocol guidance.
-
Faropenem sodium (SKU C8712): Reliable Solutions for Microbi
2026-05-02
This article addresses key challenges in cell viability, proliferation, and cytotoxicity assays by exploring how Faropenem sodium (SKU C8712) delivers reproducible, evidence-backed performance for Gram-positive, Gram-negative, and anaerobic bacterial inhibition. Scenario-driven Q&As guide researchers through protocol optimization, data interpretation, and product selection, with actionable references and real-world performance data.
-
Optimized Sulfonamides for TB: Activity with Reduced CYP 2C9
2026-05-01
This study systematically optimizes sulfaphenazole-derived sulfonamides to enhance antimycobacterial activity against Mycobacterium tuberculosis while minimizing inhibition of CYP 2C9, a key enzyme in drug metabolism. The findings reveal new structure–activity relationships and identify promising candidates with reduced drug–drug interaction risk, informing the rational design of safer anti-TB therapies.
-
3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Precision in Ce
2026-05-01
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) from APExBIO sets a new benchmark for dissecting cellular signaling mechanisms, enabling precise modulation of protein and enzymatic pathways in both in vitro and in vivo models. Its robust solubility, high purity, and data-backed workflows empower researchers to unravel complex physiological interactions with confidence.
-
CBD Attenuates Orofacial Pain and Affective Deficits via Can
2026-04-30
This study elucidates how cannabidiol (CBD) reduces both sensory and affective dimensions of orofacial inflammatory pain in mice through coordinated modulation of peripheral and central mechanisms, including cannabinoid and serotonergic signaling. The work provides new insight into the multidimensional management of pain and emotional comorbidities, highlighting translational directions for complex pain syndromes.
-
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-04-30
This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to its host cell receptor AXL, a mechanism distinct from spike–ACE2 interactions. These findings suggest new molecular links between the renin–angiotensin system and viral pathogenesis, with potential implications for cardiovascular and infectious disease research.
-
Mechanisms of Cell Death in Heart Disease: Regulated Apoptos
2026-04-29
This article examines the pivotal findings of Konstantinidis et al. (2012), who delineate the regulated nature of both apoptosis and necrosis in cardiac cell death, challenging the traditional view of necrosis as exclusively passive. Their review integrates genetic, molecular, and pharmacological evidence to highlight overlapping pathways and therapeutic potential, with practical implications for fibrosis and inflammation research.
-
BET Bromodomain Inhibitor (+)-JQ1: Translational Impact & Sy
2026-04-29
Explore the translational impact of Bromodomain Inhibitor, (+)-JQ1, with a focus on its synergy with CDK4/6 inhibitors and applications in apoptosis, inflammation, and non-hormonal male contraception. Discover protocol nuances and novel mechanistic insights not covered in conventional workflows.
-
Toremifene Citrate: Mechanistic Insights for Assay Innovatio
2026-04-28
Explore Toremifene Citrate as a cutting-edge oral selective estrogen receptor modulator, with a focus on mechanistic assay design and translational research strategies. This article delivers advanced guidance for breast cancer and hormone receptor modulation studies.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan
2026-04-28
This study uncovers the central role of IGF2BP3 as an m6A RNA-binding protein that stabilizes FZD1/7 transcripts, sustaining cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). The findings highlight a targetable signaling axis with implications for overcoming chemoresistance and improving therapeutic outcomes in TNBC.
-
Ruthenium Red in Mechanotransduction: Precision for Cytoskel
2026-04-27
Explore how Ruthenium Red, a potent Ca2+ transport inhibitor, uniquely advances mechanotransduction and cytoskeleton-dependent autophagy research. This article delivers novel assay guidance and actionable insights not covered elsewhere.
-
Safe DNA Gel Stain: Precision, Photoprotection, and Practica
2026-04-27
Explore how Safe DNA Gel Stain enables precise DNA and RNA visualization while minimizing DNA damage and enhancing workflow safety. This article goes beyond standard reviews, offering deep scientific analysis and assay-centric guidance for molecular biology researchers.